333 filings
Page 3 of 17
8-K
smxeuxbf0v
12 Jul 23
Other Events
12:00am
S-8
zif5o6pducadzrxx2ma
20 Jun 23
Registration of securities for employees
4:01pm
S-8 POS
sozhhcz
20 Jun 23
Registration of securities for employees (post-effective amendment)
4:00pm
8-K
5buqd4268xyvl5f0g
1 Jun 23
Departure of Directors or Certain Officers
4:00pm
8-K
o83j6324aq73
12 May 23
HARNESSING THE POWER OF THE INNATE IMMUNE SYSTEM INMB Webinar Phase I/II Trial of INKmune ʳ in Metastatic Castration - Resistant Prostate Cancer
8:00am
8-K
ayd691p52nyq
8 May 23
Other Events
8:02am
8-K
75x a0gw73eu
4 May 23
INmune Bio Inc. Announces First Quarter 2023 Results and Provides Business Update
4:00pm
8-K
1u00zw9u7v4 k3sx3x6
24 Apr 23
INmune Bio, Inc. to Report First Quarter 2023 Financial Results and Provide a Corporate Update on Wednesday, May 3
4:00pm
8-K
xd3t36ci0j85hmd
20 Apr 23
XPro1595 Improves Outcomes in a Mouse Model of TBI-induced Alzheimer’s Disease
4:30pm
8-K
f92v64pplrfulh exl
11 Apr 23
Other Events
4:00pm
UPLOAD
m0radqknj fve4a
10 Apr 23
Letter from SEC
12:00am
8-K
pcil0ahiwf
3 Apr 23
Other Events
9:12am
CORRESP
k91rf8v2vaywtkvb
31 Mar 23
Correspondence with SEC
12:00am
UPLOAD
t5qijm0x2t7fy4 ju
28 Mar 23
Letter from SEC
12:00am
8-K
ycup8fkuv7hkb3gl de
15 Mar 23
Other Events
4:00pm
8-K
lz2myr8wnfpsf13
3 Mar 23
INmune Bio, Inc. Announces 2022 Results and Provides Business Update
4:47pm
8-K
dysza5mflnim6i4xvx0x
22 Feb 23
Other Events
4:00pm